Completed
Are plans to do a similar type of trial in patients with metastatic triple negative breast cancer
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
How Tissue and Liquid Biopsies Are Used in Metastatic Breast Cancer Treatment - 2022-2023
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 What is a metastatic biopsy
- 3 Challenges
- 4 Questions
- 5 How do we test ER PR HER2
- 6 When to do a liquid biopsy vs a tissue biopsy
- 7 Can you take old tissue biopsies and retest
- 8 Is there a reason why microsatellite status and tumor fraction might not be determined
- 9 Tell us what you mean by DNA being cleared
- 10 When is the best time to get an ESR1 test
- 11 ESR1 status is dynamic
- 12 Can ESR1 go away
- 13 Is Neurontin prescribed clinically
- 14 Are clinical trials underway
- 15 Can CT tests capture tumor material from brain metastases
- 16 Can CT tests capture tumor material from cerebrospinal fluid
- 17 Are plans to do a similar type of trial in patients with metastatic triple negative breast cancer
- 18 Is it more or less important to get a CTDNA test in the setting of lobular cancer
- 19 Can you tell us more about the CTDNA program
